Strength
400 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378489093
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
NEVIRAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA205651On Market Since
10/29/2014
Pharmacological Classes
Cytochrome P450 2B6 Inducers
Cytochrome P450 3A Inducers
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Non-Nucleoside Analog
Non-Nucleoside Reverse Transcriptase Inhibitors
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
PHENYTOIN 125 MG/5 ML SUSP
Generic
51672406901•Sun Pharmaceutical Industries Inc.
$0.0845
per ML
PHENYTOIN 125 MG/5 ML SUSP
Generic
51672406902•Sun Pharmaceutical Industries Inc.
$0.0845
per ML
PHENYTOIN 125 MG/5 ML SUSP
Generic
59762053102•Mylan Pharmaceuticals Inc.
$0.0845
per ML
CARBAMAZEPINE 100 MG/5 ML SUSP
Generic
51672404704•Sun Pharmaceutical Industries Inc.
$0.1024
per ML
CARBAMAZEPINE 100 MG/5 ML SUSP
Generic
62135080253•Chartwell RX LLC
$0.1024
per ML
CARBAMAZEPINE 100 MG/5 ML SUSP
Generic
70954024010•ANI Pharmaceuticals, Inc.
$0.1024
per ML
EPITOL 200 MG TABLET
Generic
00093009001•Teva Pharmaceuticals USA Inc.
$0.1261
per EA
CARBAMAZEPINE 200 MG TABLET
Generic
00093010901•Teva Pharmaceuticals USA Inc.
$0.1261
per EA
CARBAMAZEPINE 200 MG TABLET
Generic
00093010910•Teva Pharmaceuticals USA Inc.
$0.1261
per EA
CARBAMAZEPINE 200 MG TABLET
Generic
00904617250•Major Pharmaceuticals
$0.1261
per EA